Global Anti-infective API Market Research Report 2021

1 Anti-infective API Market Overview

• 1.1 Product Overview and Scope of Anti-infective API
• 1.2 Anti-infective API Segment by Type
  • 1.2.1 Global Anti-infective API Market Size Growth Rate Analysis by Type 2021 VS 2027
  • 1.2.2 β-lactam Drugs
  • 1.2.3 Macrolides
  • 1.2.4 Carbapenems
  • 1.2.5 Quinolones
• 1.3 Anti-infective API Segment by Application
  • 1.3.1 Global Anti-infective API Consumption Comparison by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Antibacterial Drugs for Systemic Use
  • 1.3.3 Antiviral Drugs for Systemic Use
  • 1.3.4 Antigen for Whole Body
  • 1.3.5 Bacteria
  • 1.3.6 Immune Serum and Immunoglobulin
  • 1.3.7 Anti-mycobacterial Drugs
  • 1.3.8 Vaccine
  • 1.3.9 Other
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Anti-infective API Revenue Estimates and Forecasts (2016-2027)
  • 1.4.2 Global Anti-infective API Production Capacity Estimates and Forecasts (2016-2027)
  • 1.4.3 Global Anti-infective API Production Estimates and Forecasts (2016-2027)
• 1.5 Global Market Size by Region
  • 1.5.1 Global Anti-infective API Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
  • 1.5.2 North America Anti-infective API Estimates and Forecasts (2016-2027)
  • 1.5.3 Europe Anti-infective API Estimates and Forecasts (2016-2027)
  • 1.5.5 China Anti-infective API Estimates and Forecasts (2016-2027)
  • 1.5.5 Japan Anti-infective API Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

• 2.1 Global Anti-infective API Production Capacity Market Share by Manufacturers (2016-2021)
• 2.2 Global Anti-infective API Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Anti-infective API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.4 Global Anti-infective API Average Price by Manufacturers (2016-2021)
• 2.5 Manufacturers Anti-infective API Production Sites, Area Served, Product Types
• 2.6 Anti-infective API Market Competitive Situation and Trends
  • 2.6.1 Anti-infective API Market Concentration Rate
  • 2.6.2 Global 5 and 10 Largest Anti-infective API Players Market Share by Revenue
  • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

• 3.1 Global Production Capacity of Anti-infective API Market Share by Region (2016-2021)
• 3.2 Global Anti-infective API Revenue Market Share by Region (2016-2021)
• 3.3 Global Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.4 North America Anti-infective API Production
  • 3.4.1 North America Anti-infective API Production Growth Rate (2016-2021)
  • 3.4.2 North America Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.5 Europe Anti-infective API Production
  • 3.5.1 Europe Anti-infective API Production Growth Rate (2016-2021)
  • 3.5.2 Europe Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.6 China Anti-infective API Production
  • 3.6.1 China Anti-infective API Production Growth Rate (2016-2021)
  • 3.6.2 China Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.7 Japan Anti-infective API Production
  • 3.7.1 Japan Anti-infective API Production Growth Rate (2016-2021)
  • 3.7.2 Japan Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Anti-infective API Consumption by Region

• 4.1 Global Anti-infective API Consumption by Region
  • 4.1.1 Global Anti-infective API Consumption by Region
  • 4.1.2 Global Anti-infective API Consumption Market Share by Region
• 4.2 North America
  • 4.2.1 North America Anti-infective API Consumption by Country
  • 4.2.2 United States
  • 4.2.3 Canada
• 4.3 Europe
  • 4.3.1 Europe Anti-infective API Consumption by Country
  • 4.3.2 Germany
  • 4.3.3 France
  • 4.3.4 U.K.
  • 4.3.5 Italy
  • 4.3.6 Russia
• 4.4 Asia Pacific
  • 4.4.1 Asia Pacific Anti-infective API Consumption by Region
  • 4.4.2 China
  • 4.4.3 Japan
  • 4.4.4 South Korea
  • 4.4.5 Taiwan
  • 4.4.6 Southeast Asia
  • 4.4.7 India
  • 4.4.8 Australia
• 4.5 Latin America
  • 4.5.1 Latin America Anti-infective API Consumption by Country
  • 4.5.2 Mexico
  • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

• 5.1 Global Anti-infective API Production Market Share by Type (2016-2021)
• 5.2 Global Anti-infective API Revenue Market Share by Type (2016-2021)
• 5.3 Global Anti-infective API Price by Type (2016-2021)

6 Consumption Analysis by Application

• 6.1 Global Anti-infective API Consumption Market Share by Application (2016-2021)
• 6.2 Global Anti-infective API Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

• 7.1 North China Pharmaceutical
  • 7.1.1 North China Pharmaceutical Anti-infective API Corporation Information
  • 7.1.2 North China Pharmaceutical Anti-infective API Product Portfolio
  • 7.1.3 North China Pharmaceutical Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.1.4 North China Pharmaceutical Main Business and Markets Served
  • 7.1.5 North China Pharmaceutical Recent Developments/Updates
• 7.2 CSPC
  • 7.2.1 CSPC Anti-infective API Corporation Information
  • 7.2.2 CSPC Anti-infective API Product Portfolio
  • 7.2.3 CSPC Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.2.4 CSPC Main Business and Markets Served
  • 7.2.5 CSPC Recent Developments/Updates
• 7.3 Harbin Pharmaceutical Group Pharmaceutical General Factory
  • 7.3.1 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Corporation Information
  • 7.3.2 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product Portfolio
  • 7.3.3 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.3.4 Harbin Pharmaceutical Group Pharmaceutical General Factory Main Business and Markets Served
  • 7.3.5 Harbin Pharmaceutical Group Pharmaceutical General Factory Recent Developments/Updates
• 7.4 Henan Huaxing Pharmaceutical Factory
  • 7.4.1 Henan Huaxing Pharmaceutical Factory Anti-infective API Corporation Information
  • 7.4.2 Henan Huaxing Pharmaceutical Factory Anti-infective API Product Portfolio
  • 7.4.3 Henan Huaxing Pharmaceutical Factory Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.4.4 Henan Huaxing Pharmaceutical Factory Main Business and Markets Served
  • 7.4.5 Henan Huaxing Pharmaceutical Factory Recent Developments/Updates
• 7.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
  • 7.5.1 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Corporation Information
  • 7.5.2 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product Portfolio
  • 7.5.3 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.5.4 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Main Business and Markets Served
  • 7.5.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Recent Developments/Updates
• 7.6 Zhangjiakou Diha Pharmaceutical
  • 7.6.1 Zhangjiakou Diha Pharmaceutical Anti-infective API Corporation Information
  • 7.6.2 Zhangjiakou Diha Pharmaceutical Anti-infective API Product Portfolio
  • 7.6.3 Zhangjiakou Diha Pharmaceutical Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.6.4 Zhangjiakou Diha Pharmaceutical Main Business and Markets Served
  • 7.6.5 Zhangjiakou Diha Pharmaceutical Recent Developments/Updates
• 7.7 Shandong Lukang Medicine
  • 7.7.1 Shandong Lukang Medicine Anti-infective API Corporation Information
  • 7.7.2 Shandong Lukang Medicine Anti-infective API Product Portfolio
  • 7.7.3 Shandong Lukang Medicine Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.7.4 Shandong Lukang Medicine Main Business and Markets Served
  • 7.7.5 Shandong Lukang Medicine Recent Developments/Updates
• 7.8 Zhuhai United Laboratories
  • 7.8.1 Zhuhai United Laboratories Anti-infective API Corporation Information
  • 7.8.2 Zhuhai United Laboratories Anti-infective API Product Portfolio
  • 7.8.3 Zhuhai United Laboratories Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.8.4 Zhuhai United Laboratories Main Business and Markets Served
  • 7.7.5 Zhuhai United Laboratories Recent Developments/Updates
• 7.9 Lunan Pharmaceutical Group
  • 7.9.1 Lunan Pharmaceutical Group Anti-infective API Corporation Information
  • 7.9.2 Lunan Pharmaceutical Group Anti-infective API Product Portfolio
  • 7.9.3 Lunan Pharmaceutical Group Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.9.4 Lunan Pharmaceutical Group Main Business and Markets Served
  • 7.9.5 Lunan Pharmaceutical Group Recent Developments/Updates
• 7.10 Sandoz
  • 7.10.1 Sandoz Anti-infective API Corporation Information
  • 7.10.2 Sandoz Anti-infective API Product Portfolio
  • 7.10.3 Sandoz Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.10.4 Sandoz Main Business and Markets Served
  • 7.10.5 Sandoz Recent Developments/Updates

8 Anti-infective API Manufacturing Cost Analysis

• 8.1 Anti-infective API Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Key Raw Materials Price Trend
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Anti-infective API
• 8.4 Anti-infective API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
• 9.2 Anti-infective API Distributors List
• 9.3 Anti-infective API Customers

10 Market Dynamics

• 10.1 Anti-infective API Industry Trends
• 10.2 Anti-infective API Growth Drivers
• 10.3 Anti-infective API Market Challenges
• 10.4 Anti-infective API Market Restraints

11 Production and Supply Forecast

• 11.1 Global Forecasted Production of Anti-infective API by Region (2022-2027)
• 11.2 North America Anti-infective API Production, Revenue Forecast (2022-2027)
• 11.3 Europe Anti-infective API Production, Revenue Forecast (2022-2027)
• 11.4 China Anti-infective API Production, Revenue Forecast (2022-2027)
• 11.5 Japan Anti-infective API Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

• 12.1 Global Forecasted Demand Analysis of Anti-infective API
• 12.2 North America Forecasted Consumption of Anti-infective API by Country
• 12.3 Europe Market Forecasted Consumption of Anti-infective API by Country
• 12.4 Asia Pacific Market Forecasted Consumption of Anti-infective API by Region
• 12.5 Latin America Forecasted Consumption of Anti-infective API by Country

13 Forecast by Type and by Application (2022-2027)

• 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
  • 13.1.1 Global Forecasted Production of Anti-infective API by Type (2022-2027)
  • 13.1.2 Global Forecasted Revenue of Anti-infective API by Type (2022-2027)
  • 13.1.3 Global Forecasted Price of Anti-infective API by Type (2022-2027)
• 13.2 Global Forecasted Consumption of Anti-infective API by Application (2022-2027)

14 Research Finding and Conclusion

15 Methodology and Data Source

• 15.1 Methodology/Research Approach
  • 15.1.1 Research Programs/Design
  • 15.1.2 Market Size Estimation
  • 15.1.3 Market Breakdown and Data Triangulation
• 15.2 Data Source
  • 15.2.1 Secondary Sources
  • 15.2.2 Primary Sources
• 15.3 Author List